1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
Follow Steven Deeks: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAR-T Cells for HIV Infection Cyclophosphamide, LVgp120duoCAR-T cells, low dose, LVgp120duoCAR-T cells, high dose - HIV Infections | Phase 1 / Phase 2 | Active not recruiting | Steven Deeks | 11 | 2021-03-01 | 2026-10-14 |
| Therapeutic Vaccination in Treated HIV Disease PENNVAX-GP, INO-6145, INO-9012 - HIV-1-infection | Phase 1 / Phase 2 | Completed | Steven Deeks | 56 | 2018-08-01 | 2023-05-31 |
Acquired Immunodeficiency Syndrome (1) · HIV Infections (1)
Cyclophosphamide (1) · rocakinogene sifuplasmid (1)
United States (2)
U01AI131296 (1)